Highlights
- New trial evidence regarding the use of semaglutide for patients with type 2 diabetes and chronic kidney disease from the 61st European Renal Association (ERA) congress (23–26 May, Stockholm, Sweden)
- The role and future of genetically edited pig kidney xenotransplantation from Douglas J Anderson and Jayme E Locke (both Marnix E Heersink School of Medicine, Birmingham, USA)
- PROFILE: Debbie Brower-Maier
- News from Charing Cross Symposium 2024 (23–25th April, London, UK) vascular access and renal interventions programme, including updates on renal denervation and newly published data
- Global dialysis discussions and international vascular access training from the latest Vascular Access Society of the Americas (VASA) 2024 Vascular Access for Haemodialysis Symposium (16–18 May, Atlanta, USA)
